Smart nano-PROTACs reprogram tumor microenvironment for activatable photo-metabolic cancer immunotherapy

Protease inhibitors can modulate intratumoral metabolic processes to reprogram the immunosuppressive tumor microenvironment (TME), which however suffer from the limited efficacy and off-targeted side effects. We report smart nano-proteolysis targeting chimeras (nano-PROTACs) with phototherapeutic ab...

Full description

Bibliographic Details
Main Authors: Zhang, Chi, He, Shasha, Zeng, Ziling, Cheng, Penghui, Pu, Kanyi
Other Authors: School of Chemical and Biomedical Engineering
Format: Journal Article
Language:English
Published: 2022
Subjects:
Online Access:https://hdl.handle.net/10356/162219
_version_ 1826123395543072768
author Zhang, Chi
He, Shasha
Zeng, Ziling
Cheng, Penghui
Pu, Kanyi
author2 School of Chemical and Biomedical Engineering
author_facet School of Chemical and Biomedical Engineering
Zhang, Chi
He, Shasha
Zeng, Ziling
Cheng, Penghui
Pu, Kanyi
author_sort Zhang, Chi
collection NTU
description Protease inhibitors can modulate intratumoral metabolic processes to reprogram the immunosuppressive tumor microenvironment (TME), which however suffer from the limited efficacy and off-targeted side effects. We report smart nano-proteolysis targeting chimeras (nano-PROTACs) with phototherapeutic ablation and cancer-specific protein degradation to reprogram the TME for photo-metabolic cancer immunotherapy. This nano-PROTAC has a semiconducting polymer backbone linked with a cyclooxygenase 1/2 (COX-1/2)-targeting PROTAC peptide (CPP) via a cathepsin B (CatB)-cleavable segment. CPP can be activated by the tumor-overexpressed CatB to induce the degradation of COX-1/2 via the ubiquitin-proteasome system. The persistent degradation of COX-1/2 depletes their metabolite prostaglandin E2 which is responsible for activation of immune suppressor cells. Such a smart PROTAC strategy synergized with phototherapy specifically reprograms the immunosuppressive TME and reinvigorates antitumor immunity.
first_indexed 2024-10-01T06:03:57Z
format Journal Article
id ntu-10356/162219
institution Nanyang Technological University
language English
last_indexed 2024-10-01T06:03:57Z
publishDate 2022
record_format dspace
spelling ntu-10356/1622192022-10-10T05:24:21Z Smart nano-PROTACs reprogram tumor microenvironment for activatable photo-metabolic cancer immunotherapy Zhang, Chi He, Shasha Zeng, Ziling Cheng, Penghui Pu, Kanyi School of Chemical and Biomedical Engineering School of Physical and Mathematical Sciences Lee Kong Chian School of Medicine (LKCMedicine) Science::Medicine Cancer Immunotherapy Phototherapy Protease inhibitors can modulate intratumoral metabolic processes to reprogram the immunosuppressive tumor microenvironment (TME), which however suffer from the limited efficacy and off-targeted side effects. We report smart nano-proteolysis targeting chimeras (nano-PROTACs) with phototherapeutic ablation and cancer-specific protein degradation to reprogram the TME for photo-metabolic cancer immunotherapy. This nano-PROTAC has a semiconducting polymer backbone linked with a cyclooxygenase 1/2 (COX-1/2)-targeting PROTAC peptide (CPP) via a cathepsin B (CatB)-cleavable segment. CPP can be activated by the tumor-overexpressed CatB to induce the degradation of COX-1/2 via the ubiquitin-proteasome system. The persistent degradation of COX-1/2 depletes their metabolite prostaglandin E2 which is responsible for activation of immune suppressor cells. Such a smart PROTAC strategy synergized with phototherapy specifically reprograms the immunosuppressive TME and reinvigorates antitumor immunity. Agency for Science, Technology and Research (A*STAR) Ministry of Education (MOE) K.P. thanks Singapore Ministry of Education, Academic Research Fund Tier 1 (2019-T1-002-045, RG125/19, RT05/ 20), Academic Research Fund Tier 2 (MOE2018-T2-2-042; MOE-T2EP30220-0010), and A*STAR SERC AME Programmatic Fund (SERC A18 A8b0059) for the financial support . 2022-10-10T05:24:21Z 2022-10-10T05:24:21Z 2022 Journal Article Zhang, C., He, S., Zeng, Z., Cheng, P. & Pu, K. (2022). Smart nano-PROTACs reprogram tumor microenvironment for activatable photo-metabolic cancer immunotherapy. Angewandte Chemie (International Ed. in English), 61(8), e202114957-. https://dx.doi.org/10.1002/anie.202114957 1433-7851 https://hdl.handle.net/10356/162219 10.1002/anie.202114957 34927316 2-s2.0-85122069804 8 61 e202114957 en 2019-T1-002-045 RG125/19 RT05/20 MOE2018-T2-2-042 MOE-T2EP30220-0010 SERC A18 A8b0059 Angewandte Chemie (International ed. in English) © 2021 Wiley-VCH GmbH. All rights reserved.
spellingShingle Science::Medicine
Cancer Immunotherapy
Phototherapy
Zhang, Chi
He, Shasha
Zeng, Ziling
Cheng, Penghui
Pu, Kanyi
Smart nano-PROTACs reprogram tumor microenvironment for activatable photo-metabolic cancer immunotherapy
title Smart nano-PROTACs reprogram tumor microenvironment for activatable photo-metabolic cancer immunotherapy
title_full Smart nano-PROTACs reprogram tumor microenvironment for activatable photo-metabolic cancer immunotherapy
title_fullStr Smart nano-PROTACs reprogram tumor microenvironment for activatable photo-metabolic cancer immunotherapy
title_full_unstemmed Smart nano-PROTACs reprogram tumor microenvironment for activatable photo-metabolic cancer immunotherapy
title_short Smart nano-PROTACs reprogram tumor microenvironment for activatable photo-metabolic cancer immunotherapy
title_sort smart nano protacs reprogram tumor microenvironment for activatable photo metabolic cancer immunotherapy
topic Science::Medicine
Cancer Immunotherapy
Phototherapy
url https://hdl.handle.net/10356/162219
work_keys_str_mv AT zhangchi smartnanoprotacsreprogramtumormicroenvironmentforactivatablephotometaboliccancerimmunotherapy
AT heshasha smartnanoprotacsreprogramtumormicroenvironmentforactivatablephotometaboliccancerimmunotherapy
AT zengziling smartnanoprotacsreprogramtumormicroenvironmentforactivatablephotometaboliccancerimmunotherapy
AT chengpenghui smartnanoprotacsreprogramtumormicroenvironmentforactivatablephotometaboliccancerimmunotherapy
AT pukanyi smartnanoprotacsreprogramtumormicroenvironmentforactivatablephotometaboliccancerimmunotherapy